Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T Bever

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Journal of the Neurological Sciences|July 1, 1995
Increased cathepsin B activity in multiple sclerosis brainC T Bever, D W Garver
International Journal of Molecular Medicine|February 15, 2001
Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cellsQ Q Li, C T Bever
Neurochemical Research|August 2, 2001
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcriptionQ Q Li, C T Bever
Springer Seminars in Immunopathology|January 1, 1985
Proteinases in inflammatory demyelinating diseaseC T Bever, J N Whitaker
Brain Research. Molecular Brain Research|February 27, 2001
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cellsQ Q Li, C T Bever
Neurology|June 27, 2001
The cost of delaying treatment in multiple sclerosis: what is lost is not regainedS R Schwid, C T Bever
Neurology|October 26, 1999
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?C T Bever, G A Rosenberg
International Journal of Molecular Medicine|June 16, 2001
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell linesQ Q Li, C T Bever
Journal of Neuroimmunology|July 1, 1993
Clinical trials of interferons in multiple sclerosis. What have we learned?H S Panitch, C T Bever
Immunopharmacology and Immunotoxicology|May 1, 1997
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cellsQ Li, W A Falkler, C T Bever
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Journal of the Neurological Sciences|July 1, 1995
Increased cathepsin B activity in multiple sclerosis brainC T Bever, D W Garver
International Journal of Molecular Medicine|February 15, 2001
Mechanisms underlying the synergistic effect of Th1 cytokines on RANTES chemokine production by human glial cellsQ Q Li, C T Bever
Neurochemical Research|August 2, 2001
Th1 cytokines stimulate RANTES chemokine secretion by human astroglial cells depending on de novo transcriptionQ Q Li, C T Bever
Springer Seminars in Immunopathology|January 1, 1985
Proteinases in inflammatory demyelinating diseaseC T Bever, J N Whitaker
Brain Research. Molecular Brain Research|February 27, 2001
Glatiramer acetate blocks interleukin-1-dependent nuclear factor-kappaB activation and RANTES expression in human U-251 MG astroglial cellsQ Q Li, C T Bever
Neurology|June 27, 2001
The cost of delaying treatment in multiple sclerosis: what is lost is not regainedS R Schwid, C T Bever
Neurology|October 26, 1999
Matrix metalloproteinases in multiple sclerosis: targets of therapy or markers of injury?C T Bever, G A Rosenberg
International Journal of Molecular Medicine|June 16, 2001
Comparison of RANTES chemokine induction by Th1 cytokines in human astroglial cell linesQ Q Li, C T Bever
Journal of Neuroimmunology|July 1, 1993
Clinical trials of interferons in multiple sclerosis. What have we learned?H S Panitch, C T Bever
Immunopharmacology and Immunotoxicology|May 1, 1997
Endotoxin induces increased intracellular cathepsin B activity in THP-1 cellsQ Li, W A Falkler, C T Bever
Pageof 6